UDP-GalNAc—the core “builder” and “deliverer” of the glycosylation world

Uracil-5′-diphosphate-N-acetylgalactosamine disodium salt (UDP-GalNAc) is a key reactive sugar donor molecule in cellular glycobiology. It is not only the cornerstone of complex glycosylation modification reactions in life, but also an indispensable high value-added raw material in cutting-edge biomedicine, especially in the fields of protein drug optimization and glycobiology research.

Chemical Information

Chemical name: Uracil-5′-bisphosphate-N-acetylgalactosamine disodium salt

Common name: UDP-N-acetylgalactosamine disodium salt; UDP-GalNAc

Chemical formula: C17H28N3NaO17P2

Molecular weight: 631.35 g/mol

CAS number: 108320-87-2

Structural characteristics and biological roles

UDP-GalNAc consists of a uridine diphosphate (UDP) group linked to N-acetylgalactosamine (GalNAc) through a high-energy pyrophosphate bond. Its unique value lies in:

High-energy sugar donor: As a carrier of the "energy currency" ATP, UDP enables GalNAc to be efficiently activated and provides energy drive for glycosylation reactions.

The "initiating factor" of O-GalNAc glycosylation: UDP-GalNAc is the only natural sugar donor that initiates and proceeds protein O-GalNAc glycosylation (also known as mucin-type O-glycosylation). This process is catalyzed by a family of polypeptide N-acetylgalactosaminyltransferases (ppGalNAc-Ts).

The "codon" of cell communication: The O-glycan chain constructed from it is widely expressed on the cell surface and participates in and regulates many key life activities such as cell adhesion, signal transduction, immune recognition, and protein stability.

Main applications and advantages

1. Core tools for glycoprotein drug research and optimization

In vitro glycosylation research: In a cell-free system, purified glycosyltransferase and our high-purity UDP-GalNAc can be used to accurately introduce O-GalNAc sugar chains at specific sites of therapeutic proteins (such as antibodies, cytokines, enzymes) to study the impact of glycosylation on their efficacy, half-life and immunogenicity.

Improve drug performance: Reasonable O-GalNAc glycosylation can significantly enhance the solubility, conformational stability and resistance to protease hydrolysis of therapeutic proteins, thereby extending their half-life in vivo and improving efficacy.

2. The cornerstone of cutting-edge therapy development

Enzyme replacement therapy (ERT): The production of recombinant enzymes with correct glycosylation modifications, including O-GalNAc glycosylation, is critical for patients with inborn errors of metabolism such as lysosomal storage diseases that result in loss of enzyme function. UDP-GalNAc is one of the key raw materials in the production process of such drugs.

Chemoenzymatic synthesis of glycoproteins: As the core building block of a new generation of glycoprotein synthesis technology, UDP-GalNAc is used to accurately and uniformly construct glycoproteins with specific O-sugar chain structures in vitro, which is of great significance for the development of "designer" biopharmaceuticals and high-quality standards.

3. Basic research and biomarker discovery

Exploration of glycobiological mechanisms: Our high-purity UDP-GalNAc is an ideal reagent for studying glycosyltransferase kinetics, substrate specificity, and the function of O-glycosylation in development, cancer, and immune diseases.

Disease diagnostic potential: In various cancers (such as gastric cancer, pancreatic cancer) and autoimmune diseases, the cell surface O-glycosylation pattern will undergo characteristic changes. Studying these changes is inseparable from UDP-GalNAc and its related tools, making it a potential source of novel biomarkers.

Conclusion

Uracil-5′-diphosphate-N-acetylgalactosamine disodium salt (UDP-GalNAc) is not just a metabolic intermediate, it is a core molecule that decodes the sugar code of life and empowers the next generation of biomedical innovation. From optimizing existing protein drugs, to developing new enzyme replacement therapies, to revealing the mechanisms of disease, its value is irreplaceable.